Zydus Lifesciences Ltd.
BSE: 532321 | Sector: Health care |
NSE: ZYDUSLIFE | ISIN Code: INE010B01027 |
BSE 16:01 | 25 May | 366.25 |
-1.90 (-0.52%) |
OPEN
372.50 |
HIGH
372.50 |
LOW
363.60 |
NSE 15:57 | 25 May | 366.35 |
-1.75 (-0.48%) |
OPEN
370.95 |
HIGH
370.95 |
LOW
363.75 |
OPEN | 372.50 |
PREVIOUS CLOSE | 368.15 |
VOLUME | 99973 |
52-Week high | 668.85 |
52-Week low | 319.40 |
P/E | 34.29 |
Mkt Cap.(Rs cr) | 37,493 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Zydus Lifesciences Ltd.
Cadila Healthcare Ltd is a well known research-oriented technology-driven pharmaceutical company focused on the research areas of biotechnology formulations and Active Pharmaceutical Ingredients. They are an Indian based pharmaceutical company having their presence around the world. They are having their manufacturing facilities at Ahmedabad Ankleshwar and Vadodara in Gujarat Ponda in Goa Raigad i...> More
Zydus Lifesciences Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
37,493 | |
EPS - TTM | (![]() |
[*S] | 10.68 |
P/E Ratio | (X) | [*S] | 34.29 |
Face Value | (![]() |
1 | |
Latest Dividend | (%) | 350.00 | |
Latest Dividend Date | 28 Jul 2021 | ||
Dividend Yield | (%) | 0.68 | |
Book Value / Share | (![]() |
[*S] | 129.33 |
P/B Ratio | (![]() |
[*S] | 2.83 |
News
-
Zydus Lifesciences Q4 net dips to 24% Rs 397 cr, revenue up 5%
-
A first in India: Zydus brings new drug for uncontrolled 'bad' cholesterol
-
Top pharma firms to hike R&D spend next 5 yrs as mkt eyes $130 bn revenue
-
Cadila Healthcare changes name to Zydus Lifesciences Limited
-
Zydus Q3 net down 5% to Rs 500 cr as sales dip in US and domestic markets
Zydus Lifesciences Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 3863.8 | 3670.3 | 5.27 |
Other Income | 79.1 | -30.4 | 360.2 |
Total Income | 3942.9 | 3639.9 | 8.32 |
Total Expenses | 3161.1 | 2915.8 | 8.41 |
Operating Profit | 781.8 | 724.1 | 7.97 |
Net Profit | 448.7 | 731.6 | -38.67 |
Equity Capital | 102.4 | 102.4 | - |
Zydus Lifesciences Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Piramal Enterp. | 1817.90 | 0.44 | 43384.18 |
Biocon | 324.50 | -1.41 | 38959.47 |
Abbott India | 18068.70 | -0.68 | 38395.99 |
Zydus Lifesci. | 366.25 | -0.52 | 37493.01 |
Alkem Lab | 2973.00 | 1.38 | 35542.21 |
Aurobindo Pharma | 523.30 | -2.84 | 30660.15 |
Laurus Labs | 553.95 | -2.33 | 29766.50 |
Zydus Lifesciences Ltd - SHAREHOLDING PATTERN
|
|
Zydus Lifesciences Ltd - Research Reports
Zydus Lifesciences Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 5.50% | 5.45% | -0.85% | -1.32% |
1 Month | 7.36% | 7.39% | -5.00% | -5.47% |
3 Month | 2.78% | 2.89% | -3.78% | -3.80% |
6 Month | -20.73% | -20.72% | -8.58% | -8.61% |
1 Year | -41.16% | -41.15% | 6.15% | 5.37% |
3 Year | 44.88% | 44.92% | 36.30% | 35.31% |
Zydus Lifesciences Ltd - STOCK STRENGTH
Today's Low/High | 363.60 | 372.50 | |
Week Low/High | 334.85 | 374.00 | |
Month Low/High | 319.40 | 374.00 | |
YEAR Low/High | 319.40 | 669.00 | |
All TIME Low/High | 5.53 | 674.00 |
Quick Links for Zydus Lifesciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices